Logos Global Management LP Cullinan Oncology, Inc. Transaction History

Logos Global Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$10.17 - $19.02 $7.12 Million - $13.3 Million	700,000 New	700,000 $11.9 Million
Q2 2022 Aug 15, 2022	SELL	$7.31 - $13.55 $1.46 Million - $2.71 Million	-200,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$10.47 - $16.75 $926,155 - $1.48 Million	-88,458 Reduced 30.67%	200,000 $2.09 Million
Q2 2021 Aug 16, 2021	SELL	$24.96 - $41.25 $3.12 Million - $5.16 Million	-125,000 Reduced 30.23%	288,458 $7.43 Million
Q1 2021 May 17, 2021	BUY	$28.0 - $53.42 $11.6 Million - $22.1 Million	413,458 New	413,458 $17.2 Million

146

67.6M

612K

118K

Ticker CGEM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,612,200
Market Cap $548M
Description
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. The company's lead candidate is the CLN-081, an orally available small molecule that is in a Phase I/IIa dose escalation and expansion trial for treating patients with ...

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

Stay updated on Logos Global Management LP with notifications on news.